MustGrow Biologics Management
Management criteria checks 3/4
MustGrow Biologics' CEO is Corey Giasson, appointed in Mar 2018, has a tenure of 6.67 years. total yearly compensation is CA$302.40K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 2.24% of the company’s shares, worth €1.47M. The average tenure of the management team and the board of directors is 6.2 years and 6.5 years respectively.
Key information
Corey Giasson
Chief executive officer
CA$302.4k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 6.7yrs |
| CEO ownership | 2.2% |
| Management average tenure | 6.2yrs |
| Board average tenure | 6.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CA$424k |
| Mar 31 2024 | n/a | n/a | -CA$665k |
| Dec 31 2023 | CA$302k | CA$302k | -CA$677k |
| Sep 30 2023 | n/a | n/a | -CA$5m |
| Jun 30 2023 | n/a | n/a | -CA$5m |
| Mar 31 2023 | n/a | n/a | -CA$6m |
| Dec 31 2022 | CA$288k | CA$288k | -CA$6m |
| Sep 30 2022 | n/a | n/a | -CA$6m |
| Jun 30 2022 | n/a | n/a | -CA$4m |
| Mar 31 2022 | n/a | n/a | -CA$3m |
| Dec 31 2021 | CA$266k | CA$216k | -CA$3m |
| Sep 30 2021 | n/a | n/a | -CA$3m |
| Jun 30 2021 | n/a | n/a | -CA$3m |
| Mar 31 2021 | n/a | n/a | -CA$3m |
| Dec 31 2020 | CA$266k | CA$216k | -CA$3m |
| Sep 30 2020 | n/a | n/a | -CA$3m |
| Jun 30 2020 | n/a | n/a | -CA$3m |
| Mar 31 2020 | n/a | n/a | -CA$2m |
| Dec 31 2019 | CA$148k | CA$148k | -CA$2m |
| Sep 30 2019 | n/a | n/a | -CA$1m |
| Jun 30 2019 | n/a | n/a | -CA$1m |
| Mar 31 2019 | n/a | n/a | -CA$965k |
| Dec 31 2018 | CA$128k | CA$128k | -CA$2m |
Compensation vs Market: Corey's total compensation ($USD216.35K) is below average for companies of similar size in the German market ($USD474.67K).
Compensation vs Earnings: Corey's compensation has increased whilst the company is unprofitable.
CEO
Corey Giasson (46 yo)
6.7yrs
Tenure
CA$302,400
Compensation
Mr. Corey J. Giasson, MBA, B.Sc., serves as President at MustGrow Biologics Corp. and serves as its Chief Executive Officer and Director since March 15, 2018. Mr. Giasson had been the Chief Financial Offic...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6.7yrs | CA$302.40k | 2.24% € 1.5m | |
| CFO & Corporate Secretary | 5.9yrs | CA$277.20k | 2.07% € 1.3m | |
| COO & Director | 6.2yrs | CA$289.80k | 3.41% € 2.2m |
6.2yrs
Average Tenure
Experienced Management: 0C0's management team is seasoned and experienced (6.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6.7yrs | CA$302.40k | 2.24% € 1.5m | |
| COO & Director | 6.7yrs | CA$289.80k | 3.41% € 2.2m | |
| Independent Chairman of the Board | 6.7yrs | no data | 1.86% € 1.2m | |
| Independent Director | 3.9yrs | no data | no data | |
| Independent Director | 6.5yrs | no data | 0.40% € 257.9k | |
| Independent Director | 2.7yrs | no data | no data | |
| Independent Director | 6.5yrs | no data | 0.52% € 336.5k |
6.5yrs
Average Tenure
46yo
Average Age
Experienced Board: 0C0's board of directors are considered experienced (6.5 years average tenure).